Sure
the withdrawal does not involve any abortive or infectious risk
Home » Bioscience Institute » Prenatal Test » Advantages
the withdrawal does not involve any abortive or infectious risk
a normal venous blood sample is sufficient to proceed
it is performed starting from the 10th week of gestation (up to 24th)
boasts the largest clinical study ever published (146,958 pregnancies)
it is based on a validated and CE certified bioinformatics analysis
expected insurance coverage up to € 50,000.00
reimbursement for diagnostic details and / or genetic counseling
the test results are obtained and provided in approximately seven working days
Follow Bioscience Institute
© 2025 All rights reserved Bioscience Institute S.p.A. | Privacy Policy | Cookie Policy
Pioneering precision medicine across cancer prevention, anti-aging and longevity programs, reproductive health and stem cell technologies driving progress through science and innovation.
Advanced molecular profiling and genomic analysis to intercept cancer at its earliest stages, enabling personalized prevention strategies and early detection protocols.
Comprehensive longevity assessment and personalized interventions targeting the molecular drivers of aging, designed to optimize healthspan and extend vitality.
Cutting-edge regenerative medicine leveraging autologous stem cells and exosome therapy to restore function, enhance healing, and promote tissue regeneration across aesthetic and therapeutic applications.
State-of-the-art genomic screening for expectant parents and newborns, providing comprehensive insights into genetic health, hereditary conditions, and developmental markers.
Advanced nutraceutical formulations and exosome-based cosmetics designed to support cellular health, enhance skin regeneration, and promote overall well-being through targeted scientific innovation.

